What ASX and the Patient now need is the Clearance and jumping...

What ASX and the Patient now need is the Clearance and jumping in for the TRIAL - Bring it on - Exciting times ahead

Naming the nanoparticles as Magsense HER2 nanoparticles and performing a Breast Cancer Study with Siemens MRI machines as this will be used as the REAGENT
or
Running the Breast cancer Study with Magsense HER2 Nanoparticles utilising the Magsense DEVICE after FDA IDE Approval.

Whichever way if the study happens soon let it bring results what we long awaited

This time Bob sounding more confident to say his words "TRY TO GET INTO THE CLINIC BY THE END OF THE YEAR" Let us all hope this time the timing works out.

Performance Rights expiring - June 2020 - Interesting Times ahead

DYOR